Clinical Trial Update: TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer

View source ↗

Summary

Clinical trial update describing the combination of transarterial chemoembolization (TACE) with systemic bevacizumab for treating refractory liver metastases fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Giammaria Fiorentini | Conditions: Liver Metastasis Colon Cancer | Status: UNKNOWN